398 related articles for article (PubMed ID: 20384391)
1. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.
van den Broek MP; Groenendaal F; Egberts AC; Rademaker CM
Clin Pharmacokinet; 2010 May; 49(5):277-94. PubMed ID: 20384391
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five Metabolites.
Favié LMA; de Haan TR; Bijleveld YA; Rademaker CMA; Egberts TCG; Nuytemans DHGM; Mathôt RAA; Groenendaal F; Huitema ADR
Clin Pharmacol Ther; 2020 Nov; 108(5):1098-1106. PubMed ID: 32463940
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis.
Choi DW; Park JH; Lee SY; An SH
J Clin Pharm Ther; 2018 Aug; 43(4):484-492. PubMed ID: 29781085
[TBL] [Abstract][Full Text] [Related]
6. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.
Dostalek M; Akhlaghi F; Puzanovova M
Clin Pharmacokinet; 2012 Aug; 51(8):481-99. PubMed ID: 22668340
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system.
Tortorici MA; Kochanek PM; Poloyac SM
Crit Care Med; 2007 Sep; 35(9):2196-204. PubMed ID: 17855837
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and Other Considerations for Drug Therapy During Targeted Temperature Management.
Šunjić KM; Webb AC; Šunjić I; Palà Creus M; Folse SL
Crit Care Med; 2015 Oct; 43(10):2228-38. PubMed ID: 26237132
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia.
van der Veer MAA; de Haan TR; Franken LGW; van Hest RM; Groenendaal F; Dijk PH; de Boode WP; Simons S; Dijkman KP; van Straaten HLM; Rijken M; Cools F; Nuytemans DHGM; van Kaam AH; Bijleveld YA; Mathôt RAA;
Br J Clin Pharmacol; 2024 Jun; 90(6):1418-1427. PubMed ID: 38450797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review.
Lutz IC; Allegaert K; de Hoon JN; Marynissen H
BMJ Paediatr Open; 2020; 4(1):e000685. PubMed ID: 32577535
[TBL] [Abstract][Full Text] [Related]
11. The influence of targeted temperature management on the pharmacokinetics of drugs administered during and after cardiac arrest: a systematic review.
Crombez T; Hachimi-Idrissi S
Acta Clin Belg; 2017 Apr; 72(2):116-122. PubMed ID: 28220713
[TBL] [Abstract][Full Text] [Related]
12. Changes in cardiovascular effects of dopamine in response to graded hypothermia in vivo.
Filseth OM; How OJ; Kondratiev T; Gamst TM; Sager G; Tveita T
Crit Care Med; 2012 Jan; 40(1):178-86. PubMed ID: 21926602
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants.
Pokorna P; Wildschut ED; Vobruba V; van den Anker JN; Tibboel D
Curr Pharm Des; 2015; 21(39):5705-24. PubMed ID: 26323408
[TBL] [Abstract][Full Text] [Related]
14. Effect of Hypothermia and Targeted Temperature Management on Drug Disposition and Response Following Cardiac Arrest: A Comprehensive Review of Preclinical and Clinical Investigations.
Anderson KB; Poloyac SM; Kochanek PM; Empey PE
Ther Hypothermia Temp Manag; 2016 Dec; 6(4):169-179. PubMed ID: 27622966
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic hypothermia--pharmacology and pathophysiology].
Pedersen TF; Thorbjørnsen ML; Klepstad P; Sunde K; Dale O
Tidsskr Nor Laegeforen; 2007 Jan; 127(2):163-6. PubMed ID: 17237861
[TBL] [Abstract][Full Text] [Related]
16. [Drugs affect and are affected by body temperature].
Johansson BW
Lakartidningen; 2001 May; 98(18):2178-81. PubMed ID: 11402596
[TBL] [Abstract][Full Text] [Related]
17. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
18. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
Poulin P; Burczynski FJ; Haddad S
J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
[TBL] [Abstract][Full Text] [Related]
19. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
20. Integration of physicochemical and pharmacokinetic parameters in lead optimization: a physiological pharmacokinetic model based approach.
Benjamin B; Barman TK; Chaira T; Paliwal JK
Curr Drug Discov Technol; 2010 Sep; 7(3):143-53. PubMed ID: 20843296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
